Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Quarterly results
Appointed director
CC transcript
|
|
VION PHARMACEUTICALS INC (VION)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/15/2009 |
8-K
| Quarterly results, Conference call transcript |
| 03/13/2009 |
8-K
| Quarterly results, Conference call transcript |
| 05/06/2008 |
8-K
| Quarterly results|
Docs:
|
"VION REPORTS 2008 FIRST QUARTER RESULTS NEW HAVEN, CT, May 5, 2008 - VION PHARMACEUTICALS, INC. today announced financial results for the three-month period ended March 31, 2008. The Company reported a net loss of $8.2 million, or $1.14 per share, for the three-month period ended March 31, 2008, compared with a net loss of $8.0 million, or $1.20 per share, for the same period in 2007. Weighted-average common shares outstanding for the three months ended March 31, 2008 and 2007 were 7.2 million and 6.6 million, respectively. Operating expenses were reduced by $679,000 from $7.9 million in the 2007 quarter to $7.2 million in 2008. Interest expense increased by $766,000 over the prior year as the Company's Convertible Senior Notes, issued in February 2007, were outstanding for the entire quar..." |
|
| 03/19/2008 |
8-K
| Quarterly results, Conference call transcript|
Docs:
|
"VION REPORTS 2007 FOURTH QUARTER AND YEAR-END RESULTS NEW HAVEN, CT, March 17, 2008 - VION PHARMACEUTICALS, INC. today announced financial results for the fourth quarter and year-end of 2007. The Company reported a net loss of $34.0 million, or $5.05 per share, for the year ended December 31, 2007, compared with a net loss of $25.3 million, or $3.83 per share, for 2006. Weighted-average common shares outstanding for the years ended December 31, 2007 and December 31, 2006 were 6.7 million and 6.6 million, respectively. The net loss increased in 2007 by $8.7 million over the previous year, primarily as a result of non-cash expenses including: $5.1 million of interest expense related to Vion's convertible senior notes and $2.5 million of higher stock-based compensation expense. In addition, c...",
"Transcript of conference call held on March 18, 2008" |
|
| 05/11/2007 |
8-K
| Quarterly results, Conference call transcript |
| 03/06/2007 |
8-K
| Conference call transcript, Quarterly results |
|
|